REBECCA HOLDSWORTH: Open Payments
NPI 1770250474 · WELLS, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,744 in 89 payments from 23 companies in 2025. Trend: 2023 $1,375 · 2024 $904 · 2025 $1,744
Food & beverage: $1,744
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $296 |
| Teva Pharmaceuticals USA, Inc. | 16 | $275 |
| Novo Nordisk Inc | 8 | $176 |
| Bausch Health US, LLC | 6 | $126 |
| Janssen Pharmaceuticals, Inc | 4 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 3 | $75 |
| Neurocrine BioSciences, Inc. | 4 | $72 |
Products named: AUSTEDO XR, VRAYLAR, APLENZIN, Wegovy, SPRAVATO, XIFAXAN, FANAPT, Veozah.
Industry payments across ME — which companies pay providers there.
